Electroconvulsive therapy (ECT) may be effective and cost-effective for U.S. patients with treatment-resistant depression, according to research published online May 10 in JAMA Psychiatry.
Eric L. Ross, from the University of Michigan Medical School in Ann Arbor, and colleagues examined the cost-effectiveness of ECT versus pharmacotherapy/psychotherapy for treatment-resistant major depression. Data were included from multiple meta-analyses, randomized trials, and observational studies.
Read more: https://www.drugs.com/news/ect-effective-resistant-depression-74289.html